| [1] | Yikai WANG, Fengping WU, Chenrui LIU, Miao HAO, Shasha LYU, Miaomiao ZHANG, Shuangsuo DANG, Xin ZHANG. Dynamic change and significance of Mindin protein in chronic hepatitis B treated with PEG-IFNα-2b[J]. Journal of Clinical Hepatology, 2024, 40(1): 52-57. doi: 10.12449/JCH240110 |
| [2] | Peiyao FAN, Fuchuan WANG, Yinjie GAO, Zhiqiang XU, Yi DONG, Jianguo YAN, Lili CAO, Danni FENG, Yanwei ZHONG, Min ZHANG. Value of serum PreS1 in early prediction of HBsAg clearance after IFN-α treatment in children with HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2023, 39(8): 1825-1831. doi: 10.3969/j.issn.1001-5256.2023.08.010 |
| [3] | WANG XinRu, XIAO Li, GENG AiWen, XIAN JianChun. Pegylated interferon for treatment of chronic hepatitis B-induced thrombotic thrombocytopenic purpura:A case report[J]. Journal of Clinical Hepatology, 2020, 36(11): 2534-2536. doi: 10.3969/j.issn.1001-5256.2020.11.028 |
| [4] | Wan MoBin. Individualized treatment with pegylated interferon-α for chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(5): 930-933. doi: 10.3969/j.issn.1001-5256.2018.05.004 |
| [5] | Wang HaiYan, Zhu Li, Wang YinLing, Zhu YuePing, Zhu XiaoYan, Chai XiaoZhe, Qian Feng, Li Ming, Zhu ChuanWu. Impact of pegylated interferon versus conventional interferon on the change in peripheral CD4+CD25highT cells in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(1): 53-57. doi: 10.3969/j.issn.1001-5256.2018.01.011 |
| [6] | Li Yan, Wang Xia, Cheng LiWei, Pan XiuCheng, Dan Ben, Geng Jian, Liu RuiXia, Fu JuanJuan, Li Li. Effects of serum levels of chemokines on sustained virological response in patients with HBeAg-positive chronic hep-atitis B after treatment with pegylated interferon α-2b[J]. Journal of Clinical Hepatology, 2016, 32(3): 467-471. doi: 10.3969/j.issn.1001-5256.2016.03.013 |
| [7] | You Jia, Chen Jing, Ye QiaoXia, Zheng Qi, Zhu YueYong, Dong Jing, Liu YuRui, Jiang JiaJi. Efficacy of add- on adefovir dipivoxil at week 12 /24 in HBe Ag- positive chronic hepatitis B patients during PEG-IFNα therapy[J]. Journal of Clinical Hepatology, 2016, 32(4): 687-690. doi: 10.3969/j.issn.1001-5256.2016.04.015 |
| [8] | Sun JianMin. Efficacy of low-dose interferon α-1b combined with ribavirin and thymosin α1 versus standard treatment for chronic hepatitis C: a comparative study [J]. Journal of Clinical Hepatology, 2015, 31(1): 107-109. doi: 10.3969/j.issn.1001-5256.2015.01.023 |
| [9] | Li HuoYan, Yang ZhaoHui, Ma LiLi, Ma Long. Clinical efficacy of telbivudine and interferon in treatment of HBe Ag-positive chronic hepatitis B: a comparative study[J]. Journal of Clinical Hepatology, 2015, 31(4): 526-529. doi: 10.3969/j.issn.1001-5256.2015.04.012 |
| [10] | Li Qiang, Zhuo QiBin, Huang YuXian, Li XinYan, Chen Liang. Combination therapy and sequential therapy with interferons and nucleos( t) ide analogues against HBV[J]. Journal of Clinical Hepatology, 2015, 31(4): 495-499. doi: 10.3969/j.issn.1001-5256.2015.04.005 |
| [11] | Gao AiHua, Zhang YuGuo, Nan YueMin. Research advances in predictors of treatment responses to pegylated interferon alpha in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(4): 594-598. doi: 10.3969/j.issn.1001-5256.2015.04.029 |
| [12] | Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis . Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(11): 1106-1111. doi: 10.3969/j.issn.1001-5256.2014.11.003 |
| [13] | Zhang WenJie, Du ShaoCai, Rao HuiYing, Li ChaoXia, Tian ShuJu, Mao WeiWu, Gong YanXuan, Qu Yan. Study on the HCV gene mutation in Lanzhou and the relationship with interferon-α induced immune response[J]. Journal of Clinical Hepatology, 2011, 27(5): 515-517. |
| [14] | Pan Lei, Wei Xin, Xie YuMei, Hao ChunQiu, Wang JiuPing, Jia ZhanSheng, Bai XueFan. Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 84-85+95. |
| [15] | Cui HongLing, Hu WenJie, Feng Fei, Liu JingFang. Observation on the curative effect of interferon α, famciclovir and puccinotide injection in the treatment of chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(3): 321-322. |
| [20] | Chen RuiLie, Li JiTing, Liu Min, Fang ShaoPeng. Detection of serum β2 -microglobulin in patients with grave hepatitis and its clinical significance[J]. Journal of Clinical Hepatology, 2002, 18(5): 284-285. |
DownLoad: